Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.

Didanosine (ddI) is currently used in the management of patients infected by the human immunodeficiency virus. Rifabutin (RBT) is being extensively used for prophylaxis against Mycobacterium avium complex (MAC) infections. Due to its acid-labile characteristics, ddI must be administered with a buffe...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Li, R C, Narang, P K, Sahai, J, Cameron, W, Bianchine, J R
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1997
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163960/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9210686/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.7.1566
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!